Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer
NCT07645625
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
261
Enrollment
OTHER
Sponsor class
Conditions
Cervical Cancer
Interventions
DRUG:
Early discontinuation of Pembrolizumab with or without Bevacizumab
Sponsor
University Medical Center Groningen